Merck Q3 Earnings: Keytruda Qlex Hits $830 Million as Guidance Rises
Merck raised its adjusted profit outlook to $2.77–$2.82 per share after Q3 revenue of $18.09 billion beat estimates, powered by Keytruda Qlex's $830 million quarter and a Gardasil recovery.